Inclusion Criteria:  adult population (aged 18 years or order); patients with suspected or new diagnosed Primary aldosteronism (supporting evidence may include MRI, CT, laboratory tests); patients who had scheduled 68Ga-BNU-PSMA PET/CT scan; patients who were able to provide informed consent (signed by participant, parent or legal representative) and assent according to the guidelines of the Clinical Research Ethics Committee; healthy volunteers(aged 18 years or order).  Exclusion Criteria:  patients with pregnancy; the inability or unwillingness of the research participant, parent or legal representative to provide written informed consent.